AstraZeneca, the Anglo-Swedish pharmaceutical company, has lifted its earnings per share guidance after second-quarter results beat expectations.

The drugs company said it expected core earnings per share for 2008 to be in the $4.60 to $4.90 (232p to 247p)range, a 15 cent increase.